PT - JOURNAL ARTICLE AU - Albani, Vinicius V.L. AU - Albani, Roseane AU - Massad, Eduardo AU - Zubelli, Jorge P. TI - Nowcasting and Forecasting COVID-19 Waves: The Recursive and Stochastic Nature of Transmission AID - 10.1101/2022.04.12.22273804 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.12.22273804 4099 - http://medrxiv.org/content/early/2022/04/13/2022.04.12.22273804.short 4100 - http://medrxiv.org/content/early/2022/04/13/2022.04.12.22273804.full AB - We propose a parsimonious, yet effective, susceptible-exposed-infected-removed-type model that incorporates the time change in the transmission and death rates. The model is calibrated by Tikhonov-type regularization from official reports from New York City (NYC), Chicago, the State of São Paulo, in Brazil, and British Columbia, in Canada. To forecast, we propose different ways to extend the transmission parameter, considering its estimated values. The forecast accuracy is then evaluated using real data from the above referred places. All the techniques accurately provided forecast scenarios for periods 15 days long. One of the models effectively predicted the magnitude of the four waves of infections in NYC, including the one caused by the Omicron variant for periods of 45 days long using out-of-sample data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Fundação Butantan {grant number 01/2020], Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina [grant number 00002847/2021], Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) [grant numbers E-26/202.932/2019, E-26/202.933/2019, and E-26/202.927/2017], Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [grant numbers 305544/2011-0 and 307873/2013-7], and Khalifa University [grant number FSU-2020-09].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the datasets used in this study were publicly available. We furnish the link for the websites where they can be found.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. All the codes used to produce the data are vailable online at GitHub. https://github.com/viniciusalbani/NowcastForecastCovid